CHROMOPHOBE RENAL CELL CARCINOMA

CHROMOPHOBE RENAL CELL CARCINOMA was reported 45 times

These drug classes are most commonly taken by patients reporting CHROMOPHOBE RENAL CELL CARCINOMA:

# Drug Count
0 Corticosteroid [EPC] 13
1 Calcineurin Inhibitor Immunosuppressant [EPC] 11
2 Purine Antimetabolite [EPC] 11
3 Kinase Inhibitor [EPC] 4
4 Angiotensin 2 Receptor Blocker [EPC] 3
5 Nonsteroidal Anti-inflammatory Drug [EPC] 3
6 mTOR Inhibitor Immunosuppressant [EPC] 3
7 Antimetabolite Immunosuppressant [EPC] 2
8 Interferon beta [EPC] 2
9 Interleukin-17A Antagonist [EPC] 2
10 Nitrate Vasodilator [EPC] 2
11 Rifamycin Antibacterial [EPC] 2
12 Tumor Necrosis Factor Blocker [EPC] 2
13 Xanthine Oxidase Inhibitor [EPC] 2
14 Aldosterone Antagonist [EPC] 1
15 Alkaloid [EPC] 1
16 Alkylating Drug [EPC] 1
17 Androgen Receptor Inhibitor [EPC] 1
18 Antihypoglycemic Agent [EPC] 1
19 Bile Acid [EPC] 1
20 Calcium Channel Blocker [EPC] 1
21 Dihydropyridine Calcium Channel Blocker [EPC] 1
22 Factor Xa Inhibitor [EPC] 1
23 Folate Analog Metabolic Inhibitor [EPC] 1
24 GLP-2 Analog [EPC] 1
25 Gastrointestinal Motility Inhibitor [EPC] 1
26 Glinide [EPC] 1
27 HMG-CoA Reductase Inhibitor [EPC] 1
28 Histamine-1 Receptor Antagonist [EPC] 1
29 Histamine-2 Receptor Antagonist [EPC] 1
30 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1
31 Integrin Receptor Antagonist [EPC] 1
32 Interleukin-2 Receptor Blocking Antibody [EPC] 1
33 Interleukin-23 Antagonist [EPC] 1
34 Interleukin-4 Receptor alpha Antagonist [EPC] 1
35 Nucleoside Metabolic Inhibitor [EPC] 1
36 Platelet Aggregation Inhibitor [EPC] 1
37 Proton Pump Inhibitor [EPC] 1
38 Provitamin D2 Compound [EPC] 1
39 Serotonin Reuptake Inhibitor [EPC] 1
40 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
41 Tetracycline-class Drug [EPC] 1